Lung cancers
629 results
1 - 100
Screening for lung cancer
Lung cancers - Screening for lung cancer
Screening smokers for lung cancer with low-dose CT decreases lung cancer mortality- Treatment of lung cancer
- Drugs for preventing lung cancer in healthy people
- Exercise training for advanced lung cancer
- Interventions for smoking cessation in people diagnosed with lung cancer
- Consequences of screening for lung cancer (NELSON)
- Long-term vitamins do not prevent lung cancer
- Elemene for the treatment of lung cancer: Cochrane systematic review
- Chemotherapy for non‐small cell lung cancer
- CT screening for lung cancer: more cancers detected, no mortality benefit (DANTE)
- Italian lung cancer screening findings consistent with US National Lung Screening Trial results (ITALUNG)
- Surgery for limited‐stage small‐cell lung cancer
- Uncertain risks and benefits of CT screening for lung cancer
- Postoperative radiotherapy for non‐small cell lung cancer
- High false-positive rate with lung cancer screening
- USPSTF recommends lung cancer screening for some smokers
- Spiral CT detects early lung cancer, but screening use is premature
- Postoperative radiotherapy for non-small cell lung cancer
- Pre-operative chemotherapy in non-small cell lung cancer
- Chemotherapy for advanced non-small cell lung cancer
- Chemotherapy for brain metastases from small cell lung cancer
- Lung cancer screening may increase the likelihood of smoking cessation
- Lung cancer screening is cost effective, but only if done correctly
- Surgery for early stage non-small cell lung cancer
- Concurrent chemoradiotherapy in non-small cell lung cancer
- Second‐line chemotherapy for non‐small cell lung cancer
- Perioperative immunotherapy strategies for resectable non‐small cell lung cancer
- Palliative endobronchial brachytherapy for non‐small cell lung cancer
- Surgery for local and locally advanced non‐small cell lung cancer
- Platinum-based chemotherapy regimens for small-cell lung cancer
- Impact of low‐dose computed tomography (LDCT) screening on lung cancer‐related mortality
- Exercise training undertaken by people within 12 months of lung resection for non‐small cell lung cancer
- Concurrent chemoradiotherapy in non‐small cell lung cancer
- Adherence to lung cancer screening is relatively poor after baseline scan
- Lower mortality with CT screening for lung cancer, but at very high cost
- Palliative radiotherapy regimes for non-small cell lung cancer
- Non‐invasive interventions for improving well‐being and quality of life in patients with lung cancer
- Telehealth is effective for providing palliative care to adults with advanced lung cancer
- Chemotherapy for newly diagnosed advanced non-small-cell lung cancer
- Consolidative thoracic radiotherapy for extensive disease small cell lung cancer
- Therapeutic vaccines for advanced non‐small cell lung cancer
- Prophylactic cranial irradiation for extensive‐stage small cell lung cancer
- Systematic review: lung cancer screening with CT decreases mortality but with significant harms
- Stopping smoking after a diagnosis of early lung cancer is related to longer survival
- Lung cancer is infrequently found via screening, but follow-up imaging is common
- Annual screening chest x-ray does not reduce lung cancer mortality
- Preoperative exercise training for people with non‐small cell lung cancer
- Lung cancer screening requires additional imaging in 40% of patients in real world
- Chemotherapy and surgery versus surgery alone in non‐small cell lung cancer
- Surgery versus radiosurgery for patients with a solitary brain metastasis from non‐small cell lung cancer
- Low-dose CT screening of smokers decreases lung cancer deaths, but not overall mortality
- Lung cancer screening with low-dose CT does not affect smoking cessation rates
- Early versus late chest radiotherapy in patients with limited‐stage small cell lung cancer
- Chemotherapy versus best supportive care for extensive small cell lung cancer
- Volume-based low-dose CT screening reduces lung cancer–specific mortality (NELSON)
- Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer
- Palliative radiotherapy regimens for patients with thoracic symptoms from non‐small cell lung cancer
- Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review
- Chemotherapy for advanced non‐small cell lung cancer in the elderly population
- Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer: Cochrane systematic review
- Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
- Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
- Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission: Cochrane systematic review
- Non‐invasive positive pressure ventilation for prevention of complications after pulmonary resection in lung cancer patients
- Radical radiotherapy for stage I/II non‐small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable)
- Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non‐small cell lung cancer
- USPSTF 2021 recommends annual lung cancer screening based on shared decision-making in high-risk adults (B recommendation)
- Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease
- After community lung cancer screening, rates of follow-up imaging are lower but the rates of some procedures are higher
- Adjuvant chemotherapy for resected early-stage non-small cell lung cancer: Cochrane systematic review
- Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer: Cochrane systematic review
- Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease: Cochrane systematic review
- Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer: Cochrane systematic review
- Chemotherapy versus best supportive care for extensive small cell lung cancer: Cochrane systematic review
- Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent
- PET‐CT for assessing mediastinal lymph node involvement in patients with suspected resectable non‐small cell lung cancer
- Best first‐line therapy for people with advanced non‐small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
- First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer
- Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer
- Stereotactic body radiation therapy versus more fractionated radical radiotherapy for adults with stage I/II non‐small cell lung cancer: a systematic review and network meta‐analysis
- Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non‐small‐cell lung cancer and EGFR mutation
- Anti‐TIGIT inhibitors plus PD‐1 or PD‐L1 inhibitors versus PD‐1 or PD‐L1 inhibitors for first‐line treatment of advanced non‐small cell lung cancer
- Immune checkpoint inhibitors plus platinum‐based chemotherapy compared to platinum‐based chemotherapy with or without bevacizumab for first‐line treatment of older people with advanced non‐small cell lung cancer
- Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer